Biomarkers of Aging

Epigenetic testing offers a cutting-edge approach to understanding how lifestyle, environment, and other factors influence gene expression and overall health. This testing examines DNA methylation patterns, providing deep insights into the aging process, biological age, and potential health risks. By analyzing these biomarkers, patients and healthcare providers can take actionable steps to optimize longevity and well-being.

TruDiagnostic is a leading epigenetic lab specializing in DNA methylation to measure longevity-based biomarkers. Unlike traditional methods like telomere length, TruDiagnostic’s approach offers a more precise and predictive measurement of the aging process. This advanced testing is crucial, as aging is the number one risk factor for nearly all chronic diseases and mortality. TruDiagnostic’s reports offer clear, actionable recommendations to help slow or reverse the aging process, thereby reducing health risks over a lifetime.

TruDiagnostic has developed its biological age tests in collaboration with top research universities, including Harvard, Yale, and Duke. The DunedinPACE algorithm, licensed from Duke, is recognized globally as one of the most accurate and predictive aging measurements available. Epigenetic-based aging analytics is rapidly becoming a cornerstone of functional medicine, with significant coverage in prestigious publications such as Nature, Forbes, The Guardian, and The Wall Street Journal.

TruDiagnostic collaborates with functional, integrative, and concierge healthcare providers worldwide who focus on aging as a disease, aiming to optimize patient longevity and health outcomes. To explore more about their services and view report examples, visit their provider welcome page for comprehensive information and resources.